Detection of cytochrome P4503A (CYP3A) in human hepatic stellate cells

被引:14
|
作者
Parola, M
Robino, G
Bordone, R
Leonarduzzi, G
Casini, A
Pinzani, M
Neve, E
Bellomo, G
Dianzani, MU
IngelmanSundberg, M
Albano, E
机构
[1] UNIV TURIN,DEPT MED SCI,TURIN,ITALY
[2] UNIV FLORENCE,ALCOHOL RES CTR,I-50121 FLORENCE,ITALY
[3] UNIV FLORENCE,INST INTERNAL MED,I-50121 FLORENCE,ITALY
[4] KAROLINSKA INST,INST ENVIRONM MED,S-10401 STOCKHOLM,SWEDEN
关键词
D O I
10.1006/bbrc.1997.7307
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study we have investigated the occurrence of cytochrome P450 isoforms and of related cytochrome P450 reductase in human hepatic stellate cells (hHSC), a type of cell having relevant roles in physiopathological conditions of the liver. By performing; immunoblotting of hHSC microsomes and immunofluorescence analysis associated to confocal laser microscopy we detected only P450 enzymes belonging to the cytochrome P450 3A subfamily (CYP3A) as well as cytochrome P450 reductase. The presence of CYP3A was further indicated by detection of testosterone 6 beta-hydroxylase activity in hHSC microsomes. Other important human P450 forms were either undetectable (CYP1A2, CYP2E1, CYP2C8/9/19 and CYP4A) or bearly detectable (CYP1A1) in hHSC. This is the first study showing existence of active cytochrome P450 isoforms in human HSC. (C) 1997 Academic Press.
引用
收藏
页码:420 / 424
页数:5
相关论文
共 50 条
  • [31] Nafcillin is a potent inhibitor of cytochrome P4503A activity in humans.
    Lang, CC
    Mustafa, AM
    Jamal, SK
    Mustafa, MR
    Wood, AJJ
    Mohamed, Z
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 151 - 151
  • [32] Comon allelic variants of cytochrome P4503A and their prevalence in different populations
    Maradiegue, Ann
    Edwards, Quannetta T.
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2006, 18 (10): : 447 - 456
  • [33] CYTOCHROME P4503A AND THE DAPSONE RECOVERY RATIO - LACK OF INHIBITION BY KETOCONAZOLE
    KINIRONS, MT
    KRIVORUK, Y
    WILKINSON, GR
    WOOD, AJJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 186 - 186
  • [34] FUNCTIONAL CYTOCHROME P4503A ISOFORMS IN HUMAN EMBRYONIC-TISSUES - EXPRESSION DURING ORGANOGENESIS
    YANG, HYL
    LEE, QP
    RETTIE, AE
    JUCHAU, MR
    MOLECULAR PHARMACOLOGY, 1994, 46 (05) : 922 - 928
  • [35] Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cDNA-expressed human cytochrome P450
    Ghosal, A
    Satoh, H
    Thomas, PE
    Bush, E
    Moore, D
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (09) : 940 - 947
  • [36] Cytochrome P450 CYP3A in human renal cell cancer
    G I Murray
    M C E McFadyen
    R T Mitchell
    Y-L Cheung
    A C Kerr
    W T Melvin
    British Journal of Cancer, 1999, 79 : 1836 - 1842
  • [37] Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells
    Schuetz, EG
    Beck, WT
    Schuetz, JD
    MOLECULAR PHARMACOLOGY, 1996, 49 (02) : 311 - 318
  • [38] Influence of hepatic and intestinal cytochrome P4503A activity on the acute disposition and effects of oral transmucosal fentanyl citrate
    Kharasch, ED
    Whittington, D
    Hoffer, C
    ANESTHESIOLOGY, 2004, 101 (03) : 729 - 737
  • [39] Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients
    Schmidt, LE
    Olsen, AK
    Stentoft, K
    Rasmussen, A
    Kirkegaard, P
    Dalhoff, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (05) : 446 - 454
  • [40] REGULATION OF HEPATIC CYTOCHROME P450 3A (CYP3A) ACTIVITY BY MICRORNAS (MIRNAS)
    Vuppalanchi, Raj
    Goswami, Chirayu P.
    Nalamasu, Rohit
    Muralidharan, Sriya
    Liang Tiebing
    Bell, Lauren N.
    Jones, David R.
    Li, Lang
    Chalasani, Naga P.
    HEPATOLOGY, 2011, 54 : 718A - 718A